Evaluation of anti-cancer potential of a novel RANKL reverse signaling inhibitor
Evaluation of anti-cancer potential of a novel RANKL reverse signaling inhibitor
批准号:
21K19401
负责人:
Honma Masashi
金额:
$4.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
财政年份:
2021
资助国家:
日本
项目状态:
已结题
起止时间:
2021-07-09 至 2023-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RANKL分子を標的とした創薬の可能性
针对 RANKL 分子的药物发现的可能性
DOI:
--
发表时间:
2022
期刊:
影响因子:
--
作者:
[本間 雅, 中村 圭佑, 池淵 祐樹, 苅谷 嘉顕, 鈴木 洋史]
通讯作者:
鈴木 洋史
The potential of RANKL reverse signaling as a novel pharmacological target
RANKL 反向信号传导作为新型药理学靶点的潜力
DOI:
10.1254/fpj.22145
发表时间:
2023
期刊:
Folia Pharmacologica Japonica
影响因子:
--
作者:
[Akitoshi Nakayama, Masataka Yokoyama, Hidekazu Nagano, Naoko Hashimoto, Kazuyuki Yamagata, Kazutaka Murata, Tomoaki Tanaka, Honma Masashi]
通讯作者:
Honma Masashi
Analyses of crosstalk between RANKL reverse signaling and Wnt signaling pathways in osteoblasts
-
批准号:16H05445
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2016
-
负责人:Honma Masashi
-
依托单位:
Development of a novel biologic showing downregulation of immune responses, suppression of bone destruction and retention in the target site.
-
批准号:16K15654
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2016
-
负责人:Honma Masashi
-
依托单位:
Development of a bifunctional, anti-resorptive and pro-ostegenic, compound
-
批准号:26670656
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:Honma Masashi
-
依托单位:
Analysis of physiological roles of RANKL reverse signaling in bone homeostasis
-
批准号:24390349
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2012
-
负责人:Honma Masashi
-
依托单位:
海外基金